Lilly Asia Ventures (LAV Fund)
Biomedical VC originating from Eli Lilly in 2008, now independent; invests in biopharmaceuticals, therapeutics, medical devices, and diagnostics across Asia and the US.
Investment Focus
Founded
2011
Investment Themes
Bio/Health-Focused
China VC
Global VC
Thesis-Driven
Multi-Stage
You're viewing 1 investor
Go from one investor to the complete database.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →Similar Investors
DAYLI Partners
Seed · Series A · Series B
Seoul
Ki Tua Fund
Seed · Series A · Series B
Auckland
Novalis Biotech
Pre-Seed · Seed · Series A
Ghent
Double Point Ventures
Seed · Series A · Series B
Boston
FemHealth Ventures
Seed · Series A · Series B
New York
Kaiser Permanente Ventures
Series A · Series B · Series C
Oakland
Related Investor Lists
Still just 1 investor
Get the complete database — not just this profile.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →